Trials / Completed
CompletedNCT03201562
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- LENZ Therapeutics, Inc · Academic / Other
- Sex
- All
- Age
- 48 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and efficacy of PRX-100 compared with aceclidine alone and vehicle in the treatment of early to moderate presbyopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aceclidine+tropicamide combination | Ophthalmic Solution |
| DRUG | Aceclidine | Ophthalmic Solution |
| DRUG | Vehicle | Ophthalmic Solution |
Timeline
- Start date
- 2017-04-30
- Primary completion
- 2018-05-20
- Completion
- 2018-05-20
- First posted
- 2017-06-28
- Last updated
- 2022-09-22
- Results posted
- 2021-04-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03201562. Inclusion in this directory is not an endorsement.